MXPA02012263A - 5-aminoalquil-pirazol[4,3-d]pirimidinas. - Google Patents

5-aminoalquil-pirazol[4,3-d]pirimidinas.

Info

Publication number
MXPA02012263A
MXPA02012263A MXPA02012263A MXPA02012263A MXPA02012263A MX PA02012263 A MXPA02012263 A MX PA02012263A MX PA02012263 A MXPA02012263 A MX PA02012263A MX PA02012263 A MXPA02012263 A MX PA02012263A MX PA02012263 A MXPA02012263 A MX PA02012263A
Authority
MX
Mexico
Prior art keywords
pyrazolo
phosphodiesterase
pyrimidines
inhibiting effect
aminoalkyl
Prior art date
Application number
MXPA02012263A
Other languages
English (en)
Spanish (es)
Inventor
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA02012263A publication Critical patent/MXPA02012263A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MXPA02012263A 2000-06-29 2001-06-28 5-aminoalquil-pirazol[4,3-d]pirimidinas. MXPA02012263A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031584A DE10031584A1 (de) 2000-06-29 2000-06-29 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
PCT/EP2001/007378 WO2002000660A1 (de) 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo[4,3-d]pyrimidine mit phosphodiesterase v inhibierender wirkung

Publications (1)

Publication Number Publication Date
MXPA02012263A true MXPA02012263A (es) 2003-04-25

Family

ID=7647151

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012263A MXPA02012263A (es) 2000-06-29 2001-06-28 5-aminoalquil-pirazol[4,3-d]pirimidinas.

Country Status (21)

Country Link
US (1) US7060823B2 (https=)
EP (1) EP1296986B1 (https=)
JP (1) JP4964388B2 (https=)
KR (1) KR20030017558A (https=)
CN (1) CN1439011A (https=)
AR (1) AR028772A1 (https=)
AT (1) ATE519761T1 (https=)
AU (2) AU7970001A (https=)
BR (1) BR0111915A (https=)
CA (1) CA2410399C (https=)
CZ (1) CZ20024054A3 (https=)
DE (1) DE10031584A1 (https=)
ES (1) ES2367704T3 (https=)
HU (1) HUP0301587A3 (https=)
MX (1) MXPA02012263A (https=)
NO (1) NO20026247D0 (https=)
PL (1) PL358551A1 (https=)
RU (1) RU2271359C2 (https=)
SK (1) SK17632002A3 (https=)
WO (1) WO2002000660A1 (https=)
ZA (1) ZA200209728B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
OA13050A (en) 2003-04-29 2006-11-10 Pfizer Ltd 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.
UA80871C2 (en) * 2003-04-29 2007-11-12 Pfizer Ltd 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
GB0327319D0 (en) * 2003-11-24 2003-12-24 Pfizer Ltd Novel pharmaceuticals
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
US7572799B2 (en) 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
CA2562251C (en) * 2004-04-07 2009-04-28 Pfizer Inc. Pyrazolo'4,3-d pyrimidines
EP1809632A2 (en) * 2004-10-28 2007-07-25 Pharmacia & Upjohn Company LLC Pyrazolo[4,3-d]pyrimidine derivatives useful as pde-5 inhibitors
CA2608018C (en) 2005-05-12 2010-07-13 Pfizer Inc. Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
DE102012200360A1 (de) * 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituierte Triazine und ihre Verwendung
CA2782774A1 (en) * 2012-07-06 2014-01-06 Pharmascience Inc. Protein kinase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1739850A3 (ru) * 1987-08-31 1992-06-07 Такеда Кемикал Индастриз, Лтд (Фирма) Способ получени конденсированных производных пиразоло[3,4- @ ]пиримидина
US5075310A (en) * 1988-07-01 1991-12-24 Smith Kline & French Laboratories, Ltd. Pyrimidone derivatives as bronchodilators
GB9119704D0 (en) * 1991-09-14 1991-10-30 Pfizer Ltd Therapeutic agents
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine

Also Published As

Publication number Publication date
US20040029900A1 (en) 2004-02-12
PL358551A1 (en) 2004-08-09
NO20026247L (no) 2002-12-27
ZA200209728B (en) 2004-03-12
DE10031584A1 (de) 2002-01-10
AR028772A1 (es) 2003-05-21
NO20026247D0 (no) 2002-12-27
CZ20024054A3 (cs) 2003-04-16
JP2004501921A (ja) 2004-01-22
ES2367704T3 (es) 2011-11-07
EP1296986B1 (de) 2011-08-10
AU7970001A (en) 2002-01-08
CN1439011A (zh) 2003-08-27
SK17632002A3 (sk) 2003-05-02
CA2410399A1 (en) 2002-01-03
AU2001279700B2 (en) 2006-08-24
RU2271359C2 (ru) 2006-03-10
US7060823B2 (en) 2006-06-13
ATE519761T1 (de) 2011-08-15
JP4964388B2 (ja) 2012-06-27
KR20030017558A (ko) 2003-03-03
BR0111915A (pt) 2003-05-13
WO2002000660A1 (de) 2002-01-03
HUP0301587A2 (hu) 2003-09-29
HUP0301587A3 (en) 2005-11-28
CA2410399C (en) 2010-02-16
EP1296986A1 (de) 2003-04-02

Similar Documents

Publication Publication Date Title
AU2795000A (en) Epothilone derivatives and their use as antitumor agents
WO2002034726A3 (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
AU2002220715A1 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
MY139566A (en) Imidazolopyridines and methods of making and using the same
PL352399A1 (en) Substituted benzimidazoles
NZ290389A (en) Substituted pyrimidines typically substituted by -piperazin-1-yl
GEP20084528B (en) 5,7-DIAMINOPYRAZOLO [4,3-d] PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY
MY126527A (en) Novel dihydropyrimidines
MXPA02012263A (es) 5-aminoalquil-pirazol[4,3-d]pirimidinas.
AP2002002637A0 (en) Novel piperazine
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
SI1075477T1 (en) Novel Benzonaphthyridine-N-oxides
GB0111186D0 (en) Novel compounds
CA2311922A1 (en) Thienopyrimidines
HUP0303034A3 (en) Novel 7-azaindole-derivatives, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
MXPA03008811A (es) Procedimiento para la preparacion de 4,6-diaminopirimido (5,4-d) pirimidinas.
PL341239A1 (en) Dihydrobenzofuranes
MY133125A (en) Novel dihydroxyhexanoic acid derivatives
PT1463735E (pt) Imidazo-2,1-b-1,3,4-tiadiazol sulfonamidas
MXPA03003923A (es) Compuestos de n-([1,2,4]triazoloazinil)tiofensulfonamida como herbicidas.
BG105689A (en) Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
WO2002051848A3 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
MXPA03003714A (es) Antagonistas del receptor crf y metodos relacionados con los mismos.
IL162314A0 (en) Use of pyridine-2,4-dicarboxylic acid diamides andof pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
MXPA03007653A (es) Uso de lp82 para tratar trastornos hematopoyeticos.